Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Parrott

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Molecular Pharmaceutics|September 19, 2018
Synthesis and Characterization of Cetuximab-Docetaxel and Panitumumab-Docetaxel Antibody-Drug Conjugates for EGFR-Overexpressing Cancer TherapyDylan M Glatt, Denis R Beckford Vera, Shamit S Prabhu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 1, 2011
In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domainS Rahima Benhabbour, J Christopher Luft, Dongwook Kim, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 17, 2016
Subtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle propertiesLuke E Roode, Hailey Brighton, Tao Bo, et al.
Plos One|March 8, 2018
Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumorsDenis R Beckford Vera, Christof C Smith, Lisa M Bixby, et al.
The Journal of Clinical Investigation|February 24, 2015
RASA3 is a critical inhibitor of RAP1-dependent platelet activationLucia Stefanini, David S Paul, Raymond F Robledo, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecular Pharmaceutics|September 19, 2018
Synthesis and Characterization of Cetuximab-Docetaxel and Panitumumab-Docetaxel Antibody-Drug Conjugates for EGFR-Overexpressing Cancer TherapyDylan M Glatt, Denis R Beckford Vera, Shamit S Prabhu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 1, 2011
In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domainS Rahima Benhabbour, J Christopher Luft, Dongwook Kim, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 17, 2016
Subtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle propertiesLuke E Roode, Hailey Brighton, Tao Bo, et al.
Plos One|March 8, 2018
Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumorsDenis R Beckford Vera, Christof C Smith, Lisa M Bixby, et al.
The Journal of Clinical Investigation|February 24, 2015
RASA3 is a critical inhibitor of RAP1-dependent platelet activationLucia Stefanini, David S Paul, Raymond F Robledo, et al.
Pageof 2